Innovative Medicines Canada welcomes focus on innovation in budget 2017
Ottawa, March 22, 2017– Innovative Medicines Canada President Pamela Fralick issued the following statement in response to the tabling of the federal budget:
“Innovative Medicines Canada is pleased to see this government’s commitment to increasing innovation in Canada. We are also particularly pleased to note that the health/bio-sciences sector has been recognized as an industry that provides immense value to Canadians through jobs, growth and economic impact.
“Canada is a nation of innovators. Our members understand the opportunity that innovation presents every day, across the country. We want to ensure that the health/bio-sciences sector can continue to grow, providing high-quality jobs to Canadians, attracting investment in research and development and finding the next generation of medicines.
“Our industry has much to offer in Canada’s innovation economy and we look forward to partnering with the government through their various initiatives in health and innovation, including superclusters and the Innovation Canada Economic Strategy Tables program.
“Innovative Medicines Canada is committed to working with the Government of Canada to further the innovation agenda for the benefit of all Canadians.”
About Innovative Medicines Canada
Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.
– 30 –
For further information: